Cite

    Zou, Z., Zhang, J., Zhang, H., Liu, H., Li, Z., Cheng, D., Chen, J., Liu, L., Ni, M., Zhang, Y., Yao, J., Zhou, J., Fu, J., & Liang, Y. (2014). 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy. Journal of drug targeting, 22, 839–848. http://access.bl.uk/ark:/81055/vdc_100024970978.0x000034